Glassman Wealth Services’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3
Closed -$979 250
2023
Q4
$979 Buy
3
+1
+50% +$362 ﹤0.01% 1555
2023
Q3
$995 Sell
2
-2
-50% -$904 ﹤0.01% 1550
2023
Q2
$1.56K Buy
4
+3
+300% +$1.69K ﹤0.01% 1326
2023
Q1
$808 Buy
+1
New +$560 ﹤0.01% 1492
2022
Q1
Sell
-3
Closed -$2K 1615
2021
Q4
$2K Buy
3
+2
+200% +$1.22K ﹤0.01% 1155
2021
Q3
$1K Buy
+1
New +$854 ﹤0.01% 1261

Other funds holding AGL

Glassman Wealth Services's AGL Position: Q1 2024 in Review

Glassman Wealth Services sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 3 shares — an estimated $979 sold.

Glassman Wealth Services first reported a position in AGL in Q3 2021 and held it in 6 quarters. The position peaked at $2K in Q4 2021. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.

  • Glassman Wealth Services reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 3 Agilon Health shares in Q1 2024, an estimated $979.
  • Glassman Wealth Services first reported a position in Agilon Health in Q3 2021 and held it in 6 quarters.
  • Glassman Wealth Services's Agilon Health position peaked at $2K in Q4 2021.
  • 198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.